ArticleJournal of controlled release : official journal of the Controlled Release Society2020

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.

Baksun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.